These pathological process further promotes occurrence of insulin resistance through multiple mechanisms, including mobilization of activation of serine/threonine kinases that interfere with insulin signaling, and the dysregulation of both the sympathetic nervous and renin-angiotensin-aldosterone systems, and resulting in excessive stimulation of adrenergic and angiotensin II receptors (30). The gene discussed is MARK2; the disease is Insulin resistance.